🦊/People

Zaneta Odrowaz

InvestorFounder

Vice President of Company Creation at Frazier Life Sciences · Founder at Attovia Therapeutics

Palo Alto

FoundedAttovia Therapeutics

Find your path to Zaneta

1,797 people in our graph share verified history with Zaneta — schools, employers, funds. One of them is your warm intro.

Deep NisharunlockedZaneta: together at Stanford University (2015)
×4Zaneta: together at Stanford University
×7Zaneta: together at McKinsey & Company

About

Zaneta Odrowaz joined Frazier Life Sciences in 2022 as a Vice President focused on company creation, and co-founded Attovia Therapeutics, where she serves as Chief Business Officer. She previously was Senior Director of Corporate Development at Amunix Pharmaceuticals, contributing to its acquisition by Sanofi, and earlier held roles as Chief of Staff at Philips Neuro and Engagement Manager at McKinsey. She holds a Ph.D. in Gene Expression from The University of Manchester and a Master's in Biotechnology from Jagiellonian University, and completed a postdoctoral fellowship at Stanford University.

Invests in

Biotech

Founder at Attovia Therapeutics

Intro paths

In turn, Zaneta can intro founders to Attovia Therapeutics's investors below.

Co-founders at Attovia Therapeutics

TF
Tao Fu, MBA, M.S.Founder, Chief Executive Officer, and President
ZO
Zaneta Odrowaz, Ph.D.Chief Business Officer and Co-Founder
PV
Petter VeibyChief Scientific Officer and Co-Founder
HZ
Hangjun Zhan, Ph.D.Chief Technology Officer and Co-Founder

Experience

  1. Attovia TherapeuticsChief Business Officercurrent2023 — present
  2. Frazier Life SciencesVP Company Creationcurrent2022 — present
  3. Amunix PharmaceuticalsSenior Director Corporate Development2020 — 2022
  4. Philips NeuroChief Of Staff2018 — 2020Pleasanton, CA
  5. McKinsey & CompanyEngagement Manager2015 — 2018
  6. Oxbridge Biotech RoundtableProject Manager2014 — 2015
  7. Stanford UniversityPostdoctoral Fellow2012 — 2015Stanford, CA

Skills & more

Cell11Protein Chemistry8Genomics5Confocal Microscopy3Protein Expression4Fluorescence Microscopy7Cell Biology11Molecular Cloning7Western Blotting6Molecular Biology15Tissue Culture1Microscopy3
+12 moreImmunohistochemistryImmunoprecipitationqPCRTransfectionFlow CytometryCell CultureImmunofluorescenceProtein PurificationStrategyRNA isolationDNART-PCR

Languages English · Italian · Polish

From Zaneta's professional profile.

Investments

Per the firm's website.

Colleagues at Frazier Life Sciences

Frequently asked questions

Who is Zaneta Odrowaz?
Zaneta Odrowaz joined Frazier Life Sciences in 2022 as a Vice President focused on company creation, and co-founded Attovia Therapeutics, where she serves as Chief Business Officer. She previously was Senior Director of Corporate Development at Amunix Pharmaceuticals, contributing to its acquisition by Sanofi, and earlier held roles as Chief of Staff at Philips Neuro and Engagement Manager at McKinsey. She holds a Ph.D. in Gene Expression from The University of Manchester and a Master's in Biotechnology from Jagiellonian University, and completed a postdoctoral fellowship at Stanford University.
Where does Zaneta Odrowaz work?
Zaneta Odrowaz is Founder of Attovia Therapeutics and Vice President of Company Creation at Frazier Life Sciences.
What does Zaneta Odrowaz invest in?
Zaneta Odrowaz invests in Biotech.
What companies did Zaneta Odrowaz found?
Zaneta Odrowaz founded Attovia Therapeutics.
What companies has Zaneta Odrowaz invested in?
Investments tracked here include Attovia Therapeutics.
Where did Zaneta Odrowaz go to school?
Zaneta Odrowaz studied at The University of Manchester (Doctor of Philosophy (PhD), Gene expression); Jagiellonian University (Masters, Biotechnology).

Founder mafias

Same school

Shared employers